Venture Capital

A new study reveals employees are productive for just four hours a day. The surprising culprit isn't laziness—it's a lack of management structure.

A new Singapore venture aims to solve AI's biggest data jam, but its strategic exclusion of China signals a major geopolitical play in the tech arms race.

With key leadership promotions, AscellaHealth aims to streamline the complex path from drug discovery to patient delivery for life sciences companies worldwide.

As F1 enters a new era, Red Bull Ford Powertrains relies on Hexagon's sub-micron measurement tech to build its revolutionary 2026 engine from scratch.

Pharma veteran Pinder Sahota joins digital health firm Reset Health, signaling a strategic shift to integrated care in the new era of weight-loss drugs.

With a 135% revenue surge and a key FDA submission for its kidney transplant drug, Hansa Biopharma is poised for a pivotal year of expansion.

With co-founder Tony Ngai now Co-President and CTO, Efinix is scaling its unique FPGA technology to capture the explosive demand in the edge AI market.

Jeff Hiller, Murray Hill, and Youngmi Mayer headline a NYC summit exploring the craft of sharing personal stories, reflecting a cultural shift toward authenticity.

Defense tech firm AEVEX hires ex-Citi analyst Jason Gursky, signaling a major push to scale its unmanned systems amid a booming investment market.

YBI's new 'Landing Zone' program offers a free, equity-free path for manufacturing startups, leveraging world-class expertise to enter the US market.

Jessica Schaefer's new firm leases a lavish SoHo 'clubhouse,' betting millions on the city's AI boom and a new model for high-stakes communications.

Newsweek names Berlin Packaging a top workplace, revealing how its innovative employee ownership program and sustainability efforts create a new industry standard.

A new report shows the carbon removal market has the tools to fight climate change, but widespread corporate inaction threatens to strand vital projects.

New embedded capacitors from Empower Semiconductor promise to solve a critical power bottleneck, unlocking the next leap in AI and HPC performance.

A new survey shows private capital's rush to adopt AI is stalled by poor data, a lack of expertise, and outdated processes, creating a new competitive divide.

Discover how a brand born from cancer research is reshaping skincare with its launch at Ulta Beauty, making advanced biotech formulas accessible to everyone.

AI genomics firm partners with two major US health systems, aiming to accelerate cancer and rare disease diagnostics for 60,000 patients annually.

With a trillion-dollar wall of maturities and diverging asset performance, CREFC's upcoming conference will focus on high-yield and distressed opportunities.

Laurie Ann Goldman, the branding guru who built SPANX, is now CEO of Audien Hearing. Can she make affordable hearing aids a mainstream wellness product?

Global shocks are roiling fertilizer markets, creating a 'new normal' of price volatility. Can biological solutions offer farmers the stability they need?